Literature DB >> 17320564

Delayed-enhancement cardiovascular magnetic resonance identifies fibrous tissue in children after surgery for congenital heart disease.

Matthew A Harris1, Tiffanie R Johnson, Paul M Weinberg, Mark A Fogel.   

Abstract

OBJECTIVES: To determine whether delayed-enhancement magnetic resonance imaging can identify fibrous tissue associated with patch reconstructions in postoperative patients with congenital heart disease. Additionally, to determine whether fibrous structures not directly related to the surgical reconstruction exhibited delayed enhancement.
METHODS: Seventy-three patients underwent magnetic resonance imaging. Studies were retrospectively reviewed for the presence of delayed enhancement along the ventricular outflow tracts, cardiac valves, and where available, the ascending aorta. Three groups were identified. Group A patients (n = 34) underwent right ventricular outflow tract reconstruction and ventricular septal defect patch closure. Group B patients (n = 33) had never undergone cardiac surgery. Group C patients (n = 6) had functional single ventricle and underwent Norwood reconstruction.
RESULTS: In group A, 31 of 34 patients had delayed enhancement of the right ventricular outflow tract, and 14 of 34 had delayed enhancement of the ventricular septal defect patch (P < .001). In group B (n = 33), 1 patient with arrhythmogenic right ventricular dysplasia had delayed enhancement limited to the right ventricular outflow tract. The remainder had no delayed enhancement of either outflow tract. Delayed enhancement of the aortic valve and ascending aorta was observed in 13 of 34 (P = .002) and 10 of 26 (P = .05) group A patients, respectively, compared with 2 of 33 and 3 of 24 group B patients. In group C, delayed enhancement of the Norwood reconstruction was observed in 5 of 6 patients (P = .002).
CONCLUSIONS: Delayed-enhancement imaging detects fibrous tissue along regions of reconstruction in patients who have had surgery for congenital heart disease. Furthermore, delayed-enhancement imaging detects fibrous tissue in regions not directly related to the reconstructive surgery, including cardiac valves and the wall of the ascending aorta.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320564     DOI: 10.1016/j.jtcvs.2006.10.057

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

Review 1.  Utility of late gadolinium enhancement in pediatric cardiac MRI.

Authors:  Maryam Etesami; Robert C Gilkeson; Prabhakar Rajiah
Journal:  Pediatr Radiol       Date:  2015-12-30

2.  Prognostic Significance of Left Ventricular Fibrosis in Patients With Congenital Bicuspid Aortic Valve.

Authors:  Gentian Lluri; Pierangelo Renella; J Paul Finn; Gabriel Vorobiof; Jamil Aboulhosn; Arjun Deb
Journal:  Am J Cardiol       Date:  2017-07-14       Impact factor: 2.778

Review 3.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  Circ Cardiovasc Imaging       Date:  2022-06-21       Impact factor: 8.589

Review 4.  Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the use of cardiovascular magnetic resonance in pediatric congenital and acquired heart disease : Endorsed by The American Heart Association.

Authors:  Mark A Fogel; Shaftkat Anwar; Craig Broberg; Lorna Browne; Taylor Chung; Tiffanie Johnson; Vivek Muthurangu; Michael Taylor; Emanuela Valsangiacomo-Buechel; Carolyn Wilhelm
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-21       Impact factor: 6.903

5.  Cardiac MRI in the management of congenital heart disease in children, adolescents, and young adults.

Authors:  Pamela K Woodard; Sanjeev Bhalla; Cylen Javidan-Nejad; Andrew Bierhals; Fernando R Gutierrez; Gautam K Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

6.  Agreement of left ventricular mass in steady state free precession and delayed enhancement MR images: implications for quantification of fibrosis in congenital and ischemic heart disease.

Authors:  Sigurdur S Stephensen; Marcus Carlsson; Martin Ugander; Henrik Engblom; Goran Olivecrona; David Erlinge; Hakan Arheden
Journal:  BMC Med Imaging       Date:  2010-01-24       Impact factor: 1.930

Review 7.  Applications of cardiac magnetic resonance in electrophysiology.

Authors:  Saman Nazarian; David A Bluemke; Henry R Halperin
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02

Review 8.  Cardiovascular magnetic resonance: Diagnostic utility and specific considerations in the pediatric population.

Authors:  Frances M Mitchell; Sanjay K Prasad; Gerald F Greil; Peter Drivas; Vassilios S Vassiliou; Claire E Raphael
Journal:  World J Clin Pediatr       Date:  2016-02-08

9.  High-resolution motion compensated MRA in patients with congenital heart disease using extracellular contrast agent at 3 Tesla.

Authors:  Darius Dabir; Claas Philip Naehle; Ralf Clauberg; Juergen Gieseke; Hans H Schild; Daniel Thomas
Journal:  J Cardiovasc Magn Reson       Date:  2012-10-29       Impact factor: 5.364

10.  Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease.

Authors:  Sohrab Fratz; Taylor Chung; Gerald F Greil; Margaret M Samyn; Andrew M Taylor; Emanuela R Valsangiacomo Buechel; Shi-Joon Yoo; Andrew J Powell
Journal:  J Cardiovasc Magn Reson       Date:  2013-06-13       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.